Literature DB >> 30521477

Pancreas divisum: a reemerging risk factor for pancreatic diseases.

Serghei Covantev1.   

Abstract

Pancreas divisum (PD) is the most common developmental anatomic variant of pancreatic duct. The attention towards the PD has grown significantly since there are reports that this condition may cause acute relapsing pancreatitis, chronic pancreatitis and chronic abdominal pain syndrome. Furthermore, over the years, there have been multiple reports of PD associated with different types of tumors. There is evidence that PD can be associated with pancreatic tumors (up to 12.5% of cases). The golden standard for diagnosing PD is endoscopic retrograde cholangiopancreatography, but since it is an invasive procedure magnetic resonance cholangiopancreatography with secretin is a good alternative. In case the patient is symptomatic, endoscopic or surgical treatment should be performed. This review describes the key points of the pathophysiology, diagnostic modalities, risks of pancreatitis and tumors, as well as treatment options of PD.

Entities:  

Keywords:  acute relapsing pancreatitis; pancreas divisum; pancreatic tumors

Mesh:

Year:  2018        PMID: 30521477     DOI: 10.2478/rjim-2018-0022

Source DB:  PubMed          Journal:  Rom J Intern Med        ISSN: 1220-4749


  2 in total

1.  Pancreatic ductal anatomy: more than meets the eye.

Authors:  Serghei Covantsev; Cristina Chicu; Natalia Mazuruc; Olga Belic
Journal:  Surg Radiol Anat       Date:  2022-08-19       Impact factor: 1.354

2.  Turkish Gastroenterology Association, Pancreas Study Group, Chronic Pancreatitis Committee Consensus Report.

Authors:  Müjde Soytürk; Göksel Bengi; Dilek Oğuz; İsmail Hakkı Kalkan; Mehmet Yalnız; Mustafa Tahtacı; Kadir Demir; Elmas Kasap; Nevin Oruç; Nalan Gülşen Ünal; Orhan Sezgin; Osman Özdoğan; Engin Altıntaş; Serkan Yaraş; Erkan Parlak; Aydın Şeref Köksal; Murat Saruç; Hakan Ünal; Belkıs Ünsal; Süleyman Günay; Deniz Duman; Alper Yurçi; Sabite Kacar; Levent Filik
Journal:  Turk J Gastroenterol       Date:  2020-11       Impact factor: 1.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.